Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$460.72 USD

460.72
1,689,919

+5.98 (1.32%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $460.90 +0.18 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (148 out of 244)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis

Zacks Equity Research

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed the most recent trading day at $608.41, moving +0.46% from the previous trading session.

Sheraz Mian headshot

Top Stock Reports for Alphabet, Netflix & Thermo Fisher

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Netflix, Inc. (NFLX), and Thermo Fisher Scientific Inc. (TMO).

Zacks Equity Research

Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).

Zacks Equity Research

Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

by Zacks Equity Research

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

PerkinElmer (PKI) Receives EUA from FDA for Latest Assay

by Zacks Equity Research

PerkinElmer's (PKI) latest test receives EUA from the FDA, thereby enabling qualified laboratories to detect and differentiate SARS-CoV-2, influenza A, influenza B and RSV.

Zacks Equity Research

Quest Diagnostics (DGX) Base Arm Recovers, Testing Sales Grow

by Zacks Equity Research

Quest Diagnostics (DGX) is hopeful about the fact that COVID-19 testing remains critical as employees are returning to the workplace and students to the classroom.

Zacks Equity Research

Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed the most recent trading day at $577.35, moving +0.66% from the previous trading session.

Zacks Equity Research

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

by Zacks Equity Research

BD's (BDX) Rotarex Atherectomy System receives expanded 510 (k) clearance from the FDA that can help in the treatment of in-stent restenosis in the United States.

Zacks Equity Research

Edwards Lifesciences (EW) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Improvement in Critical Care and Surgical Structural Heart businesses is expected to have contributed to Edwards Lifesciences' (EW) third-quarter results.

Zacks Equity Research

COVID Test Demand to Aid Quest Diagnostics (DGX) Q3 Earnings

by Zacks Equity Research

In terms of strategic acquisitions, Quest Diagnostics (DGX) is likely to have secured high returns in Q3 from the acquisition of Mercy's outreach laboratory services business.

Zacks Equity Research

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DEF

Zacks Equity Research

Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DEF

Zacks Equity Research

PerkinElmer's (PKI) Arm Gets FDA EUA Nod for Latest Assay

by Zacks Equity Research

PerkinElmer's (PKI) unit receives FDA's EUA nod for its Anti-SARS-CoV-2 S1 Curve ELISA (IgG) that could aid in future understanding and provide insights on immune responses to SARS-CoV-2.

Zacks Equity Research

Thermo Fisher (TMO) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Thermo Fisher's (TMO) recent launches within Chromatography and Mass Spectrometry like Thermo Scientific Orbitrap IQ-X Tribrid Mass Spectrometer should have contributed to its Q3 top line.

Zacks Equity Research

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (TMO) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Thermo Fisher (TMO) Boosts COVID Testing With Wastewater Kit

by Zacks Equity Research

Thermo Fisher's (TMO) wastewater surveillance method is set to identify asymptomatic carriers on college campuses to monitor regional spread among communities.

Zacks Equity Research

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Equity Research

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed at $583.51 in the latest trading session, marking a +1.37% move from the prior day.

Zacks Equity Research

Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

by Zacks Equity Research

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

Zacks Equity Research

Thermo Fisher (TMO) Expands Biologics Network With New Facility

by Zacks Equity Research

Thermo Fisher's (TMO) Lengnau site will offer biopharma companies a pathway from development to large-scale production.

Zacks Equity Research

Thermo Fisher (TMO) Launches Kit for Safer Sample Collection

by Zacks Equity Research

Thermo Fisher (TMO) launches SpeciMAX Stabilized Saliva Collection Kit that can support global efforts toward SARS-CoV-2 research by ensuring safer saliva collection.

Zacks Equity Research

Why Thermo Fisher Scientific (TMO) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.